The FDA is requiring opioid pain medication manufacturers to update safety labeling with a stronger emphasis on risks from long-term use, including addiction and overdose death.

After decades of limited progress—owing to the difficulty of treating the disease and resultant market risk—glioblastoma ...

Torrent Pharmaceuticals announced that the United States Food and Drug Administration (USFDA) has successfully completed an inspection of its manufacturing facility in Visakhapatnam, Andhra Pradesh.